Dose Escalation Trial of Intra-Tumoral Injection of NIS Measles Virus in Combination With Atezolizumab
Clinical trial NCT02919449 · TERMINATED
Trial details
- NCT number
- NCT02919449
- Sponsor
- Vyriad, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-03
- Primary completion
- 2018-01-19
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.